These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26531032)

  • 1. Preventing sepsis.
    Szakmany T; Ellis G; Sharif B; Lundin RM; Hall JE
    Lancet Infect Dis; 2015 Nov; 15(11):1260. PubMed ID: 26531032
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing sepsis.
    Bermejo-Martin JF; Andaluz-Ojeda D; Almansa R; Eiros JM; Tamayo E
    Lancet Infect Dis; 2015 Nov; 15(11):1259-60. PubMed ID: 26531031
    [No Abstract]   [Full Text] [Related]  

  • 3. What next for sepsis?
    Daniels R
    Lancet Infect Dis; 2015 May; 15(5):499-501. PubMed ID: 25932572
    [No Abstract]   [Full Text] [Related]  

  • 4. Sepsis research and the poorest of the poor.
    Riviello ED; Sugira V; Twagirumugabe T
    Lancet Infect Dis; 2015 May; 15(5):501-3. PubMed ID: 25932573
    [No Abstract]   [Full Text] [Related]  

  • 5. Sepsis: a need for new solutions.
    Bosurgi R
    Lancet Infect Dis; 2015 May; 15(5):498-9. PubMed ID: 25932571
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal sepsis: an old issue needing new answers.
    Molyneux E; Gest A
    Lancet Infect Dis; 2015 May; 15(5):503-5. PubMed ID: 25932574
    [No Abstract]   [Full Text] [Related]  

  • 7. Sepsis: a roadmap for future research.
    Cohen J; Vincent JL; Adhikari NK; Machado FR; Angus DC; Calandra T; Jaton K; Giulieri S; Delaloye J; Opal S; Tracey K; van der Poll T; Pelfrene E
    Lancet Infect Dis; 2015 May; 15(5):581-614. PubMed ID: 25932591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis.
    Huttunen R; Aittoniemi J
    J Infect; 2011 Dec; 63(6):407-19. PubMed ID: 21840338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in agents used for the management of sepsis.
    Littleton MT
    Crit Care Nurs Q; 1993 Feb; 15(4):33-46. PubMed ID: 8431793
    [No Abstract]   [Full Text] [Related]  

  • 10. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act.
    Snow TAC; Cesar A; Singer M; Arulkumaran N
    Crit Care; 2022 Aug; 26(1):238. PubMed ID: 35932059
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of lactoferrin in the newborn: where do we stand?
    Sharma D; Murki A; Murki S; Pratap OT
    J Matern Fetal Neonatal Med; 2015; 28(15):1774-8. PubMed ID: 25245229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory therapies for sepsis: unexpected effects with macrolides.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S39-43. PubMed ID: 18707849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for the treatment of sepsis.
    Kotsaki A; Giamarellos-Bourboulis EJ
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):379-91. PubMed ID: 22780561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
    Giamarellos-Bourboulis E; Adamis T; Sabracos L; Raftogiannis M; Baziaka F; Tsaganos T; Koutoukas P; Plachouras D; Karayannacos P; Giamarellou H
    Scand J Infect Dis; 2005; 37(1):48-54. PubMed ID: 15764190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cornuside on experimental sepsis.
    Jiang WL; Chen XG; Zhu HB; Tian JW
    Planta Med; 2009 May; 75(6):614-9. PubMed ID: 19263342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.